|
361 |
Linagliptin
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 13, date:9.2012: 1793-1824
|
|
|
|
362 |
Linifanib
Enthalten in Drugs in R & D Bd. 10, 27.11.2012, Nr. 2, date:7.2010: 111-122
|
|
|
|
363 |
Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)
Enthalten in Drugs Bd. 71, 24.9.2012, Nr. 12, date:8.2011: 1591-1622
|
|
|
|
364 |
Long-Standing Statin Therapy and the Risk of New-Onset Diabetes in the Elderly
Enthalten in Drugs & aging Bd. 29, 31.8.2012, Nr. 1, date:1.2012: 9-13
|
|
|
|
365 |
Low-Dose Pravastatin and Age-Related Differences in Risk Factors for Cardiovascular Disease in Hypercholesterolaemic Japanese
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 9, date:9.2011: 681-692
|
|
|
|
366 |
Mammalian Target of Rapamycin (mTOR) Inhibitors
Enthalten in Drug safety Bd. 34, 21.11.2012, Nr. 2, date:2.2011: 97-115
|
|
|
|
367 |
Management of Antimicrobial Use in the Intensive Care Unit
Enthalten in Drugs Bd. 72, 21.11.2012, Nr. 4, date:3.2012: 447-470
|
|
|
|
368 |
Management of Head and Neck Cancer in Elderly Patients
Enthalten in Drugs & aging Bd. 26, 31.8.2012, Nr. 7, date:7.2009: 571-583
|
|
|
|
369 |
Managing Cognitive Dysfunction through the Continuum of Alzheimer’s Disease
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 3, date:3.2011: 213-226
|
|
|
|
370 |
Mapping the Safety Profile of Biologicals
Enthalten in Drug safety Bd. 33, 9.1.2013, Nr. 10, date:10.2010: 865-878
|
|
Administration
